TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Adesso BioProducts AB
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 1,822,902 | 1,819,243 | 1,415,787 |
Financial expenses | 7,361 | 8,120 | 8,469 |
Earnings before taxes | 112,064 | 127,045 | 71,754 |
EBITDA | 120,180 | 136,216 | 81,638 |
Total assets | 603,073 | 597,414 | 406,958 |
Current assets | 591,195 | 584,422 | 393,653 |
Current liabilities | 216,886 | 267,866 | 167,787 |
Equity capital | 296,242 | 231,676 | 139,411 |
- share capital | 67 | 73 | 74 |
Employees (average) | 21 | 21 | 20 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 49.1% | 38.8% | 34.3% |
Turnover per employee | 86,805 | 86,631 | 70,789 |
Profit as a percentage of turnover | 6.1% | 7.0% | 5.1% |
Return on assets (ROA) | 19.8% | 22.6% | 19.7% |
Current ratio | 272.6% | 218.2% | 234.6% |
Return on equity (ROE) | 37.8% | 54.8% | 51.5% |
Change turnover | 151,019 | 430,255 | -79,617 |
Change turnover % | 9% | 31% | -5% |
Chg. No. of employees | 0 | 1 | 2 |
Chg. No. of employees % | 0% | 5% | 11% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.